In brief
With over 370 million individuals requiring oxygen yearly, immediate investment is essential to address the critical shortage, particularly in low-income nations.
More than 370 million people globally require medical oxygen annually, yet less than one-third actually receive it, revealing a severe global shortage. A recent report published in The Lancet Global Health highlights this troubling reality, which was exacerbated during the Covid-19 pandemic, when countless individuals in underprivileged countries struggled to breathe even within medical facilities. Dr. Hamish Graham, a pediatrician and main author of the report, emphasized the urgent need to improve access to medical oxygen, warning that future epidemics could arise in the next 15 to 20 years. The report follows recent freezes on foreign aid programs by the Trump administration, which could further hinder efforts to alleviate this shortage. To effectively tackle the problem, an estimated $6.8 billion investment is necessary, underscoring the challenge of securing funds in the current climate. Carina King, an infectious disease epidemiologist, insists that both governments and funding organizations must prioritize the supply of medical oxygen. The supply is vital not only for treating pneumonia and respiratory issues but also for surgeries and chronic lung disorders across all age groups. As the world prepares for future health crises, bolstering oxygen availability is more critical than ever.
